Research programme: cardiovascular disease gene therapy - University of Pittsburgh
Latest Information Update: 20 Nov 2007
At a glance
- Originator University of Pittsburgh
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 04 May 2001 Preclinical development for Cardiovascular disorders in USA (Unknown route)